Stelmakh Edward
Chief Finance & Strat Officer
Stelmakh Edward has filed 5 SEC Form 4 filings (8 transaction rows) across 1 company, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Aug 24, 2026.
On the most recent filing, Stelmakh Edward is listed as Chief Finance & Strat Officer at OptimizeRx Corp. Inside the rolling window, Stelmakh Edward reported no open-market purchases and 1 open-market sale totaling $19K in OPRX.
Companies traded
Other insiders at OPRX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$19K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Stelmakh Edward made?
Stelmakh Edward has filed 5 SEC Form 4 filings (8 transaction rows) across 1 company since 2025.
Which companies does Stelmakh Edward trade?
Stelmakh Edward has filed SEC Form 4 disclosures for 1 company, including OPRX.
When was Stelmakh Edward's most recent SEC Form 4 filing?
Stelmakh Edward's most recent SEC Form 4 filing on Tracefour is dated Aug 24, 2026.
What is Stelmakh Edward's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Stelmakh Edward is listed as Chief Finance & Strat Officer.
What is Stelmakh Edward's total buy and sell value in the current window?
Inside the rolling retention window, Stelmakh Edward bought $0 and sold $19K based on SEC Form 4 filings.
What was Stelmakh Edward's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 1,388 OPRX shares on 2025-12-19, worth $19K, per SEC Form 4 filings.